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Abstract 
Purpose: To evaluate the local anesthetic and antipyretic activities of an aqueous extract of Cinchona 
officinalis (C. officinalis) in experimental animal models. 
Methods: Various doses of the aqueous extract was tested for its local anesthetic activity in guinea pigs 
and frogs using intracutaneous and plexus anesthesia, respectively. For comparison, 2 % xylocaine was 
used as a reference drug. The anti-pyretic activity of the aqueous extract was determined by Brewer’s 
yeast-induced pyrexia in rats, using aspirin (300 mg/kg) as reference. 
Results: C. officinalis extract, at concentrations of 10 and 20 %, produced significant anesthetic effects, 
of 72.12 and 88.08 %, respectively, compared with 96.86 % anesthetic effect of 2 % standard xylocaine 
(p < 0.001). In the plexus model, the mean onset of anesthetic effect was recorded at 6.44 ± 0.68 min 
versus 3.86 ± 0.42 min (p < 0.001) for the standard drug. Single administration of the extract (100, 200 
and 400 mg/kg) showed significant dose-dependent anti-pyretic activity throughout the observation 
period, which was comparable to the standard aspirin group. 
Conclusions: The findings suggest that the aqueous extract of C. officinalis has significant local 
anesthetic and anti-pyretic activities in rats. 
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The use of medicinal plants in treating ailments 
has been an integral part of traditional medicine 
for centuries. Importantly, herbal medicines play 
a vital role in developed, as well as developing, 
countries in improving primary healthcare 
because of their effective biological and 
medicinal properties with high safety margins 
and low costs. 
 
C. officinalis is one traditional medicinal plant, 
belonging to the family Rubiaceae. Its extracts 
are the main ingredient in Indian Ayurvedic 
formulations to treat various fever types, 
including malaria [1]. Apart from this, various 
peoples have used cinchona barks for different 
purposes as medicinal agents. In Brazilian 
medicine, it has been used as a digestive tract 
stimulant and fever reducer, while in South 
America generally, it is used to treat cancers, in 
Europe, cinchona extract has been used as an 
anti-protozoal and anti-spasmodic, and in the 
USA, it has been used as a digestive tonic, and 
as a treatment for cardiac disorders. 
 
Basically, Cinchona alkaloids are abundantly 
present as organic molecules that have been 
isolated from the bark of about 40 species of 
cinchona trees around globe. The major 
chemical constituents of these alkaloids are 
quinine and quinidine; cinchonine and 
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cinchonidine can also comprise up to 16 % by 
mass of total tree bark. Nearly, most of these 
extracts have been utilized in the food and 
beverage industry as bitter additives. They have 
also been used as an important anti-malarial 
drug; as a muscle spasm relaxant agent; and as 
a cardiac depressant (anti-arrhythmic). Because 
of their increasing commercial importance, 
several cinchona species are now widely 
cultivated in various parts of the world [2,3]. 
 
In the present study, we evaluated the local 
anesthetic and anti-pyretic potential of an 
aqueous extract of C. officinalis. We used some 
animal models (guinea pig, frog and albino rat) in 






Xylocaine, sodium chloride, Brewer’s yeast, and 
acetyl salicylic acid were obtained from Sigma 
Aldrich and were used without further 
processing. 
 
Preparation of C. officinalis extract 
 
Fresh stem bark of Cinchona was collected from 
Western Ghats in Tamil Nadu, India, and 
authenticated in the Pharmacognosy and 
Phytochemistry Department of Agricultural 
University, Tamil Nadu, India with a voucher 
specimen (no. PEAR-PAA-06/14) preserved in 
the department’s herbarium. The shade-dried 
stems were ground to a fine powder with a 
mechanical grinder, and 300 g of the pulverized 
powder material was extracted with double-
distilled water using a Soxhlet apparatus at 60 °C 
for approximately 48 h. The yield of the aqueous 
extract was 14.1 % (w/w) in the air-dried powder 
form, and it was stored in an air-tight container at 




The powdered aqueous extract was subjected to 
phytochemical screening analysis using 




Adult male guinea pigs weighing 300–400 g, 
frogs, and albino rats weighing 2.5–3 kg, were 
procured from the central animal house of the 
Xinxiang Medical Institute. The animals were 
acclimatized to the laboratory atmosphere for 7 
days prior to the experiment, at a controlled room 
temperature (24 ± 2 °C; relative humidity 60 – 70 
%) under a 12/12-h light-dark cycle. They were 
given a standard laboratory diet and water ad 
libitum. The experimental protocol was 
conducted after approval of the Institutional 
Animal Ethics Committee of Xinxiang Medical 
University (approval ref no. 2013/514B-21). The 
studies were performed in compliance with 
Directive 2010/63/EU on careful handling of 
animals for scientific purposes [5]. 
 
Acute oral toxicity study 
 
An acute oral toxicity study was carried out using 
the aqueous extract (0–2000 mg/kg) and the 
acute toxicity method prescribed by the 
Organization of Economic Co-operation and 
Development (OECD) Guidelines (No. 423) [6]. 
 
Evaluation of local anesthetic activity 
 
Intradermal wheal guinea pig model 
 
Guinea pigs were shaved (four different areas of 
4 cm2 each) and divided into four groups (Table 
1). The normal response of the animals to a pin 
prick was tested with 0.2 ml extract of C. 
officinalis (50 mg) injected intradermally on the 
left side of the animal, with 0.2 ml normal saline 
injected on the right. Six pin pricks were applied 
uniformly 5 min at an interval of 3 – 4 s on the 
wheal areas for up to 30 min. A skin twitch, 
usually accompanied by a squeak, was 
considered as a normal response to the pin prick. 
Animals that failed to respond or produced no 
squeak response to all pin pricks were 
considered to show a positive response to the 
anesthetic effect [7,8]. 
 
Table 1: Local anesthetic activity of aqueous extract 













A (Control) 0.9% saline 1.7 ± 0.84 5.26 
B (Test) 10% AQ 27.46 ± 4.16* 72.12* 
C (Test) 20% AQ 33.48 ± 2.04* 88.08* 
D (Standard) 2% xylocaine 37.12 ± 0.68* 96.86* 
AQ = Aqueous extract; P ˂ 0.001, vs. control. n = 6 in 
each group 
 
Plexus anesthesia in frog model 
 
Frogs were divided into three groups (Table 2). 
They were pitched and the upper part of the 
spinal cord was destroyed. Four limbs were 
nailed on the frog board and a transverse 
incision was made on the abdominal wall just 
below the sternum. The viscera were removed 
carefully through this opening and the lumbar 
plexus was exposed carefully without damaging 
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it. Then, the abdominal pouch was filled with 20 
% of the extract as a test drug. Reflex activity 
was noted by immersing the left and right limbs 
of the frog, every 2 min for up to 10 s, into 0.01 N 
HCl and normal saline, respectively. The time 
taken for the disappearance of reflex activity in 
the feet was recorded and the time of onset of 
local anesthetic action was calculated [8-12]. 
 
Table 2: Local anesthetic activity of aqueous extract 








(mean ± SEM) 
(min) 
A (Control) 0.9% saline 25.27 ± 1.65 
B (Test) 20% AQ 6.44 ± 0.68* 
C (Standard) 2% xylocaine 3.86 ± 0.42* 
AQ = aqueous extract; *P ˂ 0.001, vs. control. n = 6 in 
each group 
 
Evaluation of antipyretic activity 
 
Rats were divided into five groups. Fever was 
induced by subcutaneous injection of 20 mg/kg 
of a 20 % normal saline suspension of Brewer’s 
yeast below the nape of the neck. Initial rectal 
temperature was recorded and, after 18 h, 
animals showing a temperature difference of 
0.3–0.5 °C were selected. The control group (A) 
received vehicle (1 % Tween 80), the standard 
group (E) received aspirin 150 mg/kg, and 
groups B, C, and D received 100, 250, and 500 
mg/kg of the aqueous extract (po), respectively. 
Variation in rectal temperature was recorded at 




Statistical analysis was carried out by one-way 
ANOVA followed by Dunnett’s multiple t test. P < 
0.05 was considered to indicate statistical 
significance. GraphPad Prism5 software 
(GraphPad Software, Inc, La Jolla, CA, USA) 




The aqueous extract of C. officinalis showed blue 
fluorescence and unique colors in each test, 
suggesting the presence of alkaloids, tannins, 
flavonoids, phenolic compounds, and triterpenes 
[16]. The aqueous extract, tested at up to 2000 
mg/kg, was found to be non-toxic (category 5 
according to the OECD guidelines). 
 
The local anesthetic activity results of the 
samples in the guinea pig wheal test are 
presented in Table 1, which shows that the 
extract at 20 % concentration produced 88.08 %, 
and that at 10 % concentration produced 72.12 
% anesthetic activity; in contrast, the standard 
xylocaine showed 96.86 % activity. The extract of 
C. officinalis was significant versus the control 
group [17,18]. 
 
Table 2 shows the activity of the aqueous extract 
on plexus anesthesia in the frog model. The 
mean onset of anesthetic action for 20 % 
aqueous extract was 6.44 ± 0.68 min versus 3.86 
± 0.42 min for the standard drug xylocaine. 
Compared with the control group (saline), the 20 
% aqueous extract showed a significant 
difference in anesthetic action. 
 
The results of the anti-pyretic effects of the 
control, standard drug (aspirin), and aqueous 
extract (at doses of 100, 250, and 500 mg/kg) 
are shown in Figure 1. Aspirin and the extract at 
250 and 500 mg/kg started to show significant 
reduction in body temperature at 1 h post-dosing 
compared with the control group. The anti-pyretic 
action was sustained for up to 3 h after aspirin 
and aqueous extract administration [19,20]. 
 
 
Figure 1: Anti-pyretic activity of C.officinalis extract in 
albino rats. Closed square, Group A; open circle, 
Group B; open square, Group C; open circle, Group D; 




A comparative study of the local anesthetic 
activity of a natural plant extract was made in two 
animal species, guinea pigs and frogs. The 
aqueous extract of C. officinalis showed local 
anesthetic activity following intradermal injection 
in guinea pigs. Plant extract produced rapid 
dose-dependent local anesthesia in the wheal 
model. The results suggest that the extract was 
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able to inhibit nerve impulse conduction in the 
skin of guinea pigs. The C. officinalis extract also 
produced statistically significant rapid plexus 
anesthesia in the frog model. The onset of the 
local anesthetic effect with the aqueous extract 
was almost equal to that of the standard drug. 
This was consistent with previous reports. 
 
Basically, most of the anti-inflammatory drugs 
possess anti-pyretic effect. Here, the tested C. 
officinalis extract markedly reduced the rectal 
temperature of pyretic rats. This indicated anti-
pyretic activity of the extract in the yeast-induced 
rats, possibly because the production of 
prostaglandins was suppressed by the chemical 
constituents of the plant extract, which is 
responsible for fever induction in the central 
nervous system (CNS). Indeed, the flavonoid 
content in C. officinalis may be responsible for its 
anti-pyretic activity, by inhibiting prostaglandin 




In conclusion, the present study showed that an 
aqueous extract of plant C. officinalis had local 
anesthetic and anti-pyretic activity in guinea pigs, 
frogs, and rats. Because this is a preliminary 
report, further studies are needed to analyze the 
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